Review Article

Should Antibiotic Allergy Alerts Be Alarming?

Authors: Chris Terpening, PhD, PharmD

Abstract

Allergies to various antibiotics are reported by a substantial proportion of patients. As a result, clinical decision support programming generates frequent warnings when prescribing within electronic medical records. For a variety of reasons, the majority of these warnings may be inappropriate. Our improved understanding of the underlying physiology of allergic processes reveals that the majority of cross-reacting antibiotic allergies are implausible. Appropriate history taking and workup can invalidate many more warnings. Electronic medical records ideally should permit documentation that would facilitate more accurate entry and eliminate similar future warnings.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Macy E, Poon K-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 2009;122:778.e1-e7.
 
2. Lieberman PL. Recognition and first-line treatment of anaphylaxis. Am J Med 2014;127(1 Suppl):S6-S11.
 
3. Renaudin JM, Beaudouin E, Ponvert C, et al. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy 2013;68:929-937.
 
4. Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003;163:1409-1416.
 
5. Wolfstadt JI, Gurwitz JH, Field TS, et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 2008;23:451-458.
 
6. Overhage JM, Gandhi TK, Hope C, et al. Ambulatory computerized prescribing and preventable adverse drug events. J Patient Saf 2016;12:69-74.
 
7. Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163:2625-2631.
 
8. Jani YH, Barber N, Wong IC. Characteristics of clinical decision support alert overrides in an electronic prescribing system at a tertiary care paediatric hospital. Int J Pharm Pract 2011;19:363-366.
 
9. Nanji KC, Slight SP, Seger DL, et al. Overrides of medication-related clinical decision support alerts in outpatients. J Am Med Inform Assoc 2014;21:487-491.
 
10. Bryant AD, Fletcher GS, Payne TH. Drug interaction alert override rates in the Meaningful Use era: no evidence of progress. Appl Clin Inform 2014;5:802-813.
 
11. Hsieh TC, Kuperman GJ, Jaggi T, et al. Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system. J Am Med Inform Assoc 2004;11:482-491.
 
12. Joint Task Force on Practice Parameters American Academy of Allergy, Asthma and Immunology American College of Allergy, Asthma and Immunology. et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010;105:259-273.
 
13. Tilles SA, Slatore CG. Hypersensitivity reactions to non-beta-lactam antibiotics. Clin Rev Allergy Immunol 2003;24:221-228.
 
14. Araú L, Demoly P. Macrolides allergy. Curr Pharm Des 2008;14:2840-2862.
 
15. Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003;349:1628-1635.
 
16. Apter AJ, Kinman JL, Bilker WB, et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med 2006;119:354.e11-e19.
 
17. Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy 2014;69:420-437.
 
18. Romano A, Gaeta F, Valluzzi RL, et al. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol 2015;136:685-691.e3.
 
19. Dash CH. Penicillin allergy and the cephalosporins. J Antimicrob Chemother 1975;1(3 Suppl):107-118.
 
20. Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis 1978;137(Suppl):S74-S79.
 
21. Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol 2014;112:404-412.
 
22. Lehmann DF. The metabolic rationale for a lack of cross-reactivity between sulfonamide antimicrobials and other sulfonamide-containing drugs. Drug Metab Lett 2012;6:129-133.
 
23. Ghimire S, Kyung E, Lee JH, et al. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. J Clin Pharm Ther 2013;38:196-202.
 
24. Carrington DM, Earl HS, Sullivan TJ. Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 1987;79:442-447.
 
25. Ahmad A, Ramakrishnan A, McLean MA, et al. Use of optical biosensor technology to study immunological cross-reactivity between different sulfonamide drugs. Anal Biochem 2002;300:177-184.
 
26. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-693.
 
27. Wulf NR, Matuszewski KA. Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? Am J Health Syst Pharm 2013;70:1483-1494.
 
28. Macy E, Ho NJ. Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management. Ann Allergy Asthma Immunol 2012;108:88-93.
 
29. Omer HM, Hodson J, Thomas SK, et al. Multiple drug intolerance syndrome: a large-scale retrospective study. Drug Saf 2014;37:1037-1045.
 
30. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014;133:790-796.
 
31. Thornhill MH, Dayer MJ, Prendergast B, et al. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother 2015;70:2382-2388.
 
32. Brockow K, Garvey LH, Aberer W, et al. Skin test concentrations for systemically administered drugs-an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013;68:702-712.
 
33. Macy E. Penicillin allergy: optimizing diagnostic protocols, public health implications, and future research needs. Curr Opin Allergy Clin Immunol 2015;15:308-313.